Angiotech, a pioneer in medical device R&D, is now focusing efforts on licensing and marketing their new commercial products. The bold cover statement of this annual reflects the company's belief that their business, though successful already, can still be improved through commercialization. The title also introduces the AR's parallel narrative, that patient outcomes can and should be improving as medical technology advances.

Recognized in Black Book AR 100.